NCT07621744

Brief Summary

This study evaluated the effects of parasternal block and wound site infiltration on postoperative pain in patients undergoing median sternotomy. Patients were allocated to receive parasternal block, wound site infiltration, or standard systemic analgesia. Salivary opiorphin levels and postoperative pain scores were assessed to compare analgesic effectiveness between the groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
Completed

Started Jan 2024

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

2 years

First QC Date

May 21, 2026

Last Update Submit

May 30, 2026

Conditions

Keywords

Parasternal BlockWound Site InfiltrationOpiorphinMedian SternotomyPostoperative Analgesia

Outcome Measures

Primary Outcomes (1)

  • Change in Salivary Opiorphin Level

    Salivary opiorphin levels were measured using ELISA to evaluate the analgesic effect of the study interventions.

    Baseline, 3 minutes after sternotomy, and postoperative 6 hours

Secondary Outcomes (6)

  • Postoperative Pain Intensity Assessed by the Visual Analogue Scale

    At 1, 2, 4, 8, 12, and 24 hours after extubation

  • Additional Analgesic Requirement

    Within the first 24 hours after extubation

  • Total Opioid Consumption

    Within the first 24 postoperative hours

  • Extubation Time

    Immediately after surgery until tracheal extubation, assessed up to 24 hours postoperatively

  • Intensive Care Unit Length of Stay

    From postoperative intensive care unit admission until intensive care unit discharge, assessed up to 7 days postoperatively

  • +1 more secondary outcomes

Study Arms (3)

Parasternal Block Group

EXPERIMENTAL

Participants in this group received ultrasound-guided parasternal block with local anesthetic before surgical incision, in addition to standard perioperative systemic analgesia.

Procedure: Parasternal blocks

Wound Site Infiltration Group

ACTIVE COMPARATOR

Participants in this group received wound site infiltration with local anesthetic before surgical incision, in addition to standard perioperative systemic analgesia.

Procedure: Wound Site Infiltration

Standard Analgesia Group

NO INTERVENTION

Participants in this group received standard perioperative systemic analgesia without local anesthetic intervention at the surgical site.

Interventions

Ultrasound-guided parasternal block was performed with local anesthetic before surgical incision.

Parasternal Block Group

Local anesthetic infiltration was performed at the surgical wound site before surgical incision.

Wound Site Infiltration Group

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for surgery through median sternotomy
  • Patients who provided informed consent

You may not qualify if:

  • Age under 30 years
  • Presence of ischemic, inflammatory, or systemic disease, except cardiovascular disease
  • Use of analgesic medication within the last 24 hours
  • Diagnosis of psychiatric disorder
  • Presence of any oral pathology, including active dental caries, aphthous lesions, or salivary gland inflammation
  • Prolonged intubation or inability to be separated from mechanical ventilation for more than 8 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University

Erzurum, 25240, Turkey (Türkiye)

Location

Related Publications (4)

  • Parida SK, Guruprasad T, Krishnakumar VB, Ravi RP. A study of salivary opiorphin levels using different anesthetic drugs and techniques - A randomized controlled clinical study. J Stomatol Oral Maxillofac Surg. 2018 Jun;119(3):169-171. doi: 10.1016/j.jormas.2017.11.017. Epub 2017 Dec 13.

    PMID: 29247820BACKGROUND
  • Ozdogan MS, Gungormus M, Ince Yusufoglu S, Ertem SY, Sonmez C, Orhan M. Salivary opiorphin in dental pain: A potential biomarker for dental disease. Arch Oral Biol. 2019 Mar;99:15-21. doi: 10.1016/j.archoralbio.2018.12.006. Epub 2018 Dec 15.

    PMID: 30590229BACKGROUND
  • Gavcar EG, Kabukcu Basay B, Avci E, Basay O. Relationship between saliva opiorphin levels, pain threshold, and cutting number in adolescents with non suicidal self injury. J Psychiatr Res. 2022 Jul;151:611-618. doi: 10.1016/j.jpsychires.2022.05.030. Epub 2022 May 24.

    PMID: 35636040BACKGROUND
  • Yilmaz N, Baygin O, Tuzuner T, Mentese A, Demir S. Determination of the effect of two different methods of dental anesthesia on pain level in pediatric patients: A cross-over, randomized trial. Niger J Clin Pract. 2022 Nov;25(11):1853-1863. doi: 10.4103/njcp.njcp_289_22.

    PMID: 36412293BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Muhammed Enes Aydin, professor

    Ataturk University Department of Anesthesiology and Reanimation

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and postoperative outcome assessors were blinded to group assignment. In addition, laboratory personnel performing salivary opiorphin measurements were blinded to treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were assigned to one of three parallel groups: parasternal block, wound site infiltration, or standard systemic analgesia.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 21, 2026

First Posted

June 2, 2026

Study Start

January 1, 2024

Primary Completion

January 1, 2026

Study Completion

January 12, 2026

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to participant privacy and confidentiality considerations.

Locations